Youth, which is forgiven everything, forgives itself nothing: age, which forgives itself everything, is forgiven nothing.
-George Bernard Shaw
The proportion of older people in the general population is steadily increasing worldwide, with the most rapid growth in low-and middle-income countries.
(1) This demographic change is to be celebrated, because it is the consequence of socioeconomic development and better life expectancy. However, population aging also has important implications for society -in diverse areas including health systems, labor markets, public policy, social programs, and family dynamics. (2) A successful response to the aging population will require capitalizing on the opportunities that this transition offers, as well as effectively addressing its challenges.
Chronic kidney disease (CKD) is an important public health problem that is characterized by poor health outcomes and very high health care costs. CKD is a major risk multiplier in patients with diabetes, hypertension, heart disease and stroke -all of which are key causes of death and disability in older people.(3) Since the prevalence of CKD is higher in older people, the health impact of population aging will depend in part on how the kidney community responds. 
Epidemiology of aging
The key drivers of population aging are socioeconomic development and increasing prosperity -which result in lower perinatal, infant and childhood mortality; lower risk of death in early adulthood due to accidents and unsafe living conditions; and improving survival of middle-aged and older people due to chronic disease. The resulting increases in life expectancy (together with the lower birth rates that typically accompany socioeconomic development) mean that older people account for a larger proportion of the general population. (1) The extent of the resulting changes in population characteristics can be startling, especially for developing countries (Figure 1 ). These demographic changes have dramatic potential implications for conditions such as CKD, for which the prevalence increases with age.
CKD is common in older people and its prevalence increases in parallel with age
It has been known for decades that estimated glomerular filtration rate (eGFR) declines in parallel with age. (5) The prevalence of CKD among females in the Chinese general population increases from 7.4% among those aged 18-39 years to 18.0% and 24.2% among those aged 60-69 and 70 years respectively. (6) Relative increases in the prevalence of CKD with age are equally striking for populations in the U.S, Canada and Europe,(7-9) although there are between-country differences in the absolute prevalence.
At older ages, an increased proportion of prevalent CKD cases has low eGFR alone (as compared to albuminuria alone, or both low eGFR and albuminuria).(10) Although this might suggest that many older people with CKD can expect lower rates of kidney function loss, available data are inconclusive -and current knowledge does not allow clinicians to reliably distinguish between those whose CKD will and will not progress.
As for other age groups, the incidence of dialysis-dependent kidney failure has steadily increased among older people over the last few decades: in the U.S, a 57% age-adjusted increase in the number of incident octogenarians and nonagenarians was noted between 1996 and 2003 alone.(11) Despite this increase, patients aged >80 years are still less likely to initiate dialysis than those aged 75-79 years -although a large recent study suggested that the risk of developing very low eGFR (<15 ml/min/1.73m 2 ) is similar for older and younger adults. (12) It is uncertain whether this discrepancy is due to between-age differences in the true rate of progressive kidney function loss, the risk of death due to competing causes, patient views about dialysis, or physician practices. (12, 13) Regardless of the explanation, the aging population will likely lead to continued increases in the number of older people with severe CKD.
CKD is harmful but treatable if patients at risk are identified
Like younger people, older people with advanced CKD are at increased risk of death, kidney failure, myocardial infarction and stroke compared to otherwise similar people with normal or mildly reduced eGFR. (14, 15) Although death is by far the most common of these adverse outcomes, this does not mean that older patients with clinically relevant CKD cannot benefit from timely specialist referral.
With appropriate management, patients with advanced CKD (regardless of age) may benefit from slower loss of kidney function (potentially preventing kidney failure), better control of metabolic consequences such as acidosis, anemia and hyperphosphatemia, lower risk of 
Research needs
Although much is known about chronic kidney disease in older populations, a great deal remains to be learned. Many trials of therapies for CKD have excluded older patients (28) -and most do not provide guidance on how to manage comorbidities that often accompany CKD but may lead to competing therapeutic priorities. More information is needed on how to accurately identify people who will progress to kidney failure -and among these, the subset that can expect reasonable life expectancy and quality of life if they opt for dialysis treatment. 
